Adaptive Biotechnologies Corporation
USD20.78
-0.62 (-2.90%)
CEO
Chad Robins
IPO Date
2019-06-27
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$21.08
Prev. Close
$21.40
Day Low
$20.70
Day High
$21.55
52W Low
$9.96
52W High
$21.64
Market Cap
$3.33B
Volume
0.22M
| -5.5 |
| 31 Dec 2023 | FY | 55.6% | -132.3% | -73.0% | -34.1% | 0.32 | 4.66 | -3.1 |
| 31 Dec 2022 | FY | 68.7% | -108.0% | -43.1% | -23.4% | 0.23 | 5.12 | -5.4 |
| 31 Dec 2021 | FY | 68.1% | -134.3% | -34.3% | -22.4% | 0.19 | 3.54 | -19.0 |
| 31 Dec 2020 | FY | 77.1% | -148.6% | -19.7% | -13.1% | 0.15 | 6.91 | -53.1 |
| 31 Dec 2019 | FY | 73.8% | -80.6% | -12.0% | -7.5% | 0.06 | 7.82 | -54.2 |
| 31 Dec 2018 | FY | 64.7% | -83.4% | 18.0% | -14.0% | -2.17 | 7.93 | -91.5 |
| 31 Dec 2017 | FY | 59.2% | -111.4% | 19.1% | -11.8% | -2.50 | 9.77 | -99.2 |
| -45.8 |
| 30 Sept 2025 | Q3 | 80.7% | 10.2% | 4.7% | 1.9% | 0.40 | 3.38 | 59.7 |
| 30 Jun 2025 | Q2 | 69.4% | -43.5% | -14.3% | -5.2% | 0.47 | 2.84 | -17.3 |
| 31 Mar 2025 | Q1 | 67.6% | -56.9% | -15.7% | -5.8% | 0.46 | 2.92 | -9.3 |
| 31 Dec 2024 | Q4 | 62.0% | -71.0% | -16.6% | -6.2% | 0.44 | 2.89 | -6.5 |
| 30 Sept 2024 | Q3 | 64.1% | -69.1% | -14.3% | -5.7% | 0.41 | 3.52 | -5.9 |
| 30 Jun 2024 | Q2 | 55.3% | -107.0% | -19.1% | -7.9% | 0.39 | 3.99 | -2.9 |
| 31 Mar 2024 | Q1 | 56.9% | -113.5% | -17.3% | -7.7% | 0.35 | 4.51 | -2.4 |
| 31 Dec 2023 | Q4 | 57.2% | -151.7% | -22.5% | -10.5% | 0.32 | 4.66 | -2.6 |